ANI Pharmaceuticals, Inc. (ANIP) ownership: Top institutional holder: BlackRock, Inc. ($211.28M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 2747492.00 | $211.28M | 2026-03-31 |
| VANGUARD GROUP INC | 1305068.00 | $103.02M | 2025-12-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 823064.00 | $63.29M | 2026-03-31 |
| Soleus Capital Management, L.P. | 820243.00 | $63.08M | 2026-03-31 |
| STATE STREET CORP | 771587.00 | $59.34M | 2026-03-31 |
| TANG CAPITAL MANAGEMENT LLC | 707500.00 | $54.41M | 2026-03-31 |
| GOLDENTREE ASSET MANAGEMENT LP | 667981.00 | $51.30M | 2026-03-31 |
| BlackRock Fund Advisors | 794666.00 | $48.17M | 2016-12-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-06-05 | |
| Sell | null | 2026-05-21 | |
| Sell | null | 2026-05-21 | |
| Sell | null | 2026-05-21 | |
| Sell | null | 2026-05-21 | |
| Sell | null | 2026-05-21 |
Back to ANIP overview · ANIP earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.